The Venture Codex Logo

The Venture Codex

Global Bioenergies

5 rue Henri Desbruères, Evry-Courcouronnes, Essonne, 91000, France

Overview

Global Bioenergies develops biobased chemical production processes to convert plant-derived resources into compounds used in cosmetics, energy and materials. The company launched the LAST® make-up brand in 2021 and is marketing Isonaturane® 12 to major cosmetics companies. Its core technology focuses on producing isobutene via a two-step process that first makes DMA (prenic acid) from residual sugars and then converts DMA into isobutene. Future plans include optimizing the Horizon 2 production chain, reducing production costs, and preparing the commercial roll-out of the ViaViridia plant (Horizon 3). The company is listed on Euronext Growth Paris (FR0011052257 - ALGBE). Public- and industry-backed projects and partnerships aim to scale industrial production and support the development of green value industries in France. Global Bioenergies develops a fermentation-based process to convert renewable resources (residual sugars and agricultural and forestry waste) into isobutene and has replicated the approach to propylene and butadiene. The company operates an industrial pilot and was constructing a demo plant in Germany to advance industrial development. It coordinates the IBN-One joint venture with Cristal Union to prepare a first full-scale commercial plant and continues improving process performance. IBN-One's plant was projected to become operational in 2019 with an annual capacity of approximately 50,000 tonnes. Global Bioenergies highlights the carbon-reduction benefits of its bio-sourced isobutene and is engaging industrial partners such as Cristal Union for feedstock supply and L'Oréal to test cosmetic derivatives. The company is listed on Alternext, Euronext Paris (FR0011052257 - ALGBE). Global Bioenergies is developing a synthetic biology fermentation process to produce isobutene from renewable feedstocks such as sugar, cereals and agricultural or forestry waste. The company operates an industrial pilot and has begun construction of a demo plant in Germany. It has replicated its approach to produce other gaseous olefins, including propylene and butadiene. Global Bioenergies is preparing a first full-scale plant through a joint venture with Cristal Union called IBN-One and has created a German subsidiary, IBN-Two, to gather funds and operate a German fermentative isobutene plant. The company is listed on Alternext, Euronext Paris. The recent financing is intended to adapt its isobutene process to specific industrial environments and strengthen its leadership in fermentative isobutene.

Total raised
$15M
Funding rounds
4
Latest round
Debt Financing
Latest activity
Mar 2023

Industries

  • Biotechnology
  • Renewable Energy
Visit website

Recent funding

  1. Debt Financing

    Mar 2023

    $2M

  2. Equity

    Jun 2016

    $6M

  3. Debt Financing

    Jun 2015

    $2M

Team

  • Marc Delcourt

    Co-Founder and Chief Executive Officer

    LinkedIn
  • Bernard Chaud

    Director of Industrial Strategy

    LinkedIn
  • Jean-Baptiste Barbaroux

    Head of Corporate Development

  • Martin Stephan

    Chief Business Officer

    LinkedIn